In this edition:
Real-world combinations of DMARDs in PsA
An AI screening tool for PsA
Placebo response rates in PsA trials & geographic recruiting patterns
Real-world switching patterns with first-line advanced therapies in PsA
Rheumatologists leaving hospital for private practice: gender differences
Non-articular pain & patient-reported outcomes in early RA
MACE risk with high-dose folic acid + methotrexate in RA
Glucocorticoid discontinuation with DMARDs in RA
Sustained drug-free remission in RA
A new digital therapeutic for axSpA
Please login below to download this issue (PDF)